223 related articles for article (PubMed ID: 30853306)
21. Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T.
Lagemaat MW; Philips BW; Vos EK; van Uden MJ; Fütterer JJ; Jenniskens SF; Scheenen TW; Maas MC
Invest Radiol; 2017 May; 52(5):295-301. PubMed ID: 28002239
[TBL] [Abstract][Full Text] [Related]
22. Technique of Multiparametric MR Imaging of the Prostate.
Purysko AS; Rosenkrantz AB
Radiol Clin North Am; 2018 Mar; 56(2):211-222. PubMed ID: 29420977
[TBL] [Abstract][Full Text] [Related]
23. Magnetic Resonance Imaging-Defined Prostate-Specific Antigen Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy.
Bhat NR; Vetter JM; Andriole GL; Shetty AS; Ippolito JE; Kim EH
Urology; 2019 Apr; 126():152-157. PubMed ID: 30580005
[TBL] [Abstract][Full Text] [Related]
24. Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.
Hedgire SS; Eberhardt SC; Borczuk R; McDermott S; Harisinghani MG
Abdom Imaging; 2014 Oct; 39(5):1036-51. PubMed ID: 24566965
[TBL] [Abstract][Full Text] [Related]
25. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
Sheridan AD; Nath SK; Syed JS; Aneja S; Sprenkle PC; Weinreb JC; Spektor M
AJR Am J Roentgenol; 2018 Feb; 210(2):347-357. PubMed ID: 29112469
[TBL] [Abstract][Full Text] [Related]
26. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric prostate MRI: technical conduct, standardized report and clinical use.
Manfredi M; Mele F; Garrou D; Walz J; Fütterer JJ; Russo F; Vassallo L; Villers A; Emberton M; Valerio M
Minerva Urol Nefrol; 2018 Feb; 70(1):9-21. PubMed ID: 28494579
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric magnetic resonance imaging: Current role in prostate cancer management.
Ueno Y; Tamada T; Bist V; Reinhold C; Miyake H; Tanaka U; Kitajima K; Sugimura K; Takahashi S
Int J Urol; 2016 Jul; 23(7):550-7. PubMed ID: 27184019
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
[TBL] [Abstract][Full Text] [Related]
30. Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer.
Rhee H; Thomas P; Shepherd B; Gustafson S; Vela I; Russell PJ; Nelson C; Chung E; Wood G; Malone G; Wood S; Heathcote P
J Urol; 2016 Oct; 196(4):1261-7. PubMed ID: 27220897
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.
Bryant RJ; Hobbs CP; Eyre KS; Davies LC; Sullivan ME; Shields W; Sooriakumaran P; Verrill CL; Gleeson FV; MacPherson RE; Hamdy FC; Brewster SF
J Urol; 2019 Mar; 201(3):510-519. PubMed ID: 30266332
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric MR imaging of the Prostate: Pitfalls in Interpretation.
Thomas S; Oto A
Radiol Clin North Am; 2018 Mar; 56(2):277-287. PubMed ID: 29420982
[TBL] [Abstract][Full Text] [Related]
33. What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.
Borofsky S; George AK; Gaur S; Bernardo M; Greer MD; Mertan FV; Taffel M; Moreno V; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Radiology; 2018 Jan; 286(1):186-195. PubMed ID: 29053402
[TBL] [Abstract][Full Text] [Related]
34. Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.
Christidis D; McGrath S; Leaney B; O'Sullivan R; Lawrentschuk N
Urology; 2018 Jan; 111():136-138. PubMed ID: 28823635
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging of prostate cancer.
Guneyli S; Erdem CZ; Erdem LO
Clin Imaging; 2016; 40(4):601-9. PubMed ID: 27317204
[TBL] [Abstract][Full Text] [Related]
36. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
37. MRI of the pelvis: a guide to incidental findings for musculoskeletal radiologists.
Childs DD; Leyendecker JR
Semin Musculoskelet Radiol; 2008 Mar; 12(1):83-103. PubMed ID: 18382947
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric MRI in the diagnosis of prostate cancer - a generational change.
Thompson LC; Pokorny MR
Aust Fam Physician; 2015 Aug; 44(8):597-602. PubMed ID: 26510151
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric magnetic resonance imaging and prostate cancer: what's new?
Catalá V; Vilanova JC; Gaya JM; Algaba F; Martí T
Radiologia; 2017; 59(3):196-208. PubMed ID: 28236452
[TBL] [Abstract][Full Text] [Related]
40. Is Prostate Imaging Reporting and Data System Version 2 Sufficiently Discovering Clinically Significant Prostate Cancer? Per-Lesion Radiology-Pathology Correlation Study.
Lee MS; Moon MH; Kim YA; Sung CK; Woo H; Jeong H; Son H
AJR Am J Roentgenol; 2018 Jul; 211(1):114-120. PubMed ID: 29702017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
